article

1. The Rapid Naming Test: Neuroanatomical validity and clinical utility..  Alzheimer's & dementia (Amsterdam, Netherlands).  17:-. 2025
2. Tablet-based Cognitive Assessment Tool (TabCAT) in a multisite study of early-onset Alzheimer's disease..  Alzheimer's & dementia : the journal of the Alzheimer's Association.  21:-. 2025
3. Blood-based Alzheimer's disease biomarkers in a behavioral neurology clinic: Real-world implementation, clinical utility, and diagnostic performance..  Alzheimer's & dementia : the journal of the Alzheimer's Association.  21:-. 2025
4. Identifying sex- and gender-specific endocrinological, lifestyle, psychosocial, and socio-cultural targets for Alzheimer's disease prevention in Africans: The Female Brain Health and Endocrine Research in Africa (FemBER-Africa) project..  Alzheimer's & dementia : the journal of the Alzheimer's Association.  21:-. 2025
5. Development and validation of the TabCAT-EXAMINER: A tablet-based executive functioning battery for research and clinical trials..  Journal of the International Neuropsychological Society : JINS.  31:242-253. 2025
6. Peruvian validation and standardization of the TabCAT-brain health assessment..  Frontiers in public health.  -. 2025
7. Plasma Inflammatory Biomarkers Link to Worse Cognition Among Africans With HIV..  Journal of acquired immune deficiency syndromes (1999).  99:405-416. 2025
8. Diagnostic Reversion in Dementia Care: A Real-World Analysis of Mild Cognitive Impairment Diagnoses Following Dementia in a Large Electronic Medical Record System..  medRxiv : the preprint server for health sciences.  2025
9. Enhancing early detection of cognitive impairment in primary care with the TabCAT-BHA..  Alzheimer's & dementia : the journal of the Alzheimer's Association.  21:-. 2025
10. Reduced levels of angiogenesis biomarkers predict increased symptom severity in Chinese Americans with Alzheimer's disease with demographic-specific effect..  Neurocase.  31:82-91. 2025
11. Gaps in biomedical research in frontotemporal dementia: A call for diversity and disparities focused research..  Alzheimer's & dementia : the journal of the Alzheimer's Association.  20:9014-9036. 2024
12. Stakeholder-informed pragmatic trial protocol of the TabCAT-BHA for the detection of cognitive impairment in primary care..  BMC primary care.  25:-. 2024
13. Cultural adaptation of the brain health assessment for early detection of cognitive impairment in Southeast Nigeria..  Frontiers in dementia.  -. 2024
14. Alzheimer's disease as a women's health challenge: a call for action on integrative precision medicine approaches..  npj women's health.  2:-. 2024
15. Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer's disease..  Brain communications.  6:-. 2024
16. Characterizing Multimorbidity Prevalence and Adverse Outcomes in Ethnically and Culturally Diverse Sub-Populations in India: Gaps, Opportunities, and Future Directions..  International journal of environmental research and public health.  21. 2024
17. C9orf72 Repeat Expansion Initially Presenting as Late-Onset Bipolar Disorder With Psychosis..  The neurologist.  29:109-112. 2024
18. Scalable plasma and digital cognitive markers for diagnosis and prognosis of Alzheimer's disease and related dementias..  Alzheimer's & dementia : the journal of the Alzheimer's Association.  20:2089-2101. 2024
19. Assessing processing speed and its neural correlates in the three variants of primary progressive aphasia with a non-verbal tablet-based task..  Cortex; a journal devoted to the study of the nervous system and behavior.  165-177. 2023
20. Longitudinal clinical, cognitive and biomarker profiles in dominantly inherited versus sporadic early-onset Alzheimer's disease..  Brain communications.  5:-. 2023
21. Gaps in clinical research in frontotemporal dementia: A call for diversity and disparities-focused research..  Alzheimer's & dementia : the journal of the Alzheimer's Association.  19:5817-5836. 2023
22. The structural and social determinants of Alzheimer's disease related dementias..  Alzheimer's & dementia : the journal of the Alzheimer's Association.  19:3171-3185. 2023
23. Feasibility and Acceptability of a Multidisciplinary Academic Telemedicine System for Memory Care in Response to COVID-19..  Neurology. Clinical practice.  12:e199-e209. 2022
24. A novel approach for the detection of cognitive impairment and delirium risk in older patients undergoing spine surgery..  Journal of the American Geriatrics Society.  71:227-234. 2022
25. Neurocognitive health of older adults experiencing homelessness in Oakland, California..  Frontiers in neurology.  -. 2022
26. Facilitators and Barriers to Dementia Assessment and Diagnosis: Perspectives From Dementia Experts Within a Global Health Context..  Frontiers in neurology.  -. 2022
27. Lessons from Detecting Cognitive Impairment Including Dementia (DetectCID) in Primary Care..  Journal of Alzheimer's disease : JAD.  86:655-665. 2022
28. Assessment of Racial/Ethnic Disparities in Timeliness and Comprehensiveness of Dementia Diagnosis in California..  JAMA neurology.  78:657-665. 2021
29. Perils of Race-Based Norms in Cognitive Testing: The Case of Former NFL Players..  JAMA neurology.  78:377-378. 2021
30. Detecting Alzheimer's disease biomarkers with a brief tablet-based cognitive battery: sensitivity to Aβ and tau PET..  Alzheimer's research & therapy.  13:-. 2021
31. A Brief Digital Cognitive Assessment for Detection of Cognitive Impairment in Cuban Older Adults..  Journal of Alzheimer's disease : JAD.  79:85-94. 2021
32. Current State of Self-Administered Brief Computerized Cognitive Assessments for Detection of Cognitive Disorders in Older Adults: A Systematic Review..  The journal of prevention of Alzheimer's disease.  8:267-276. 2021
33. Global Perspectives on Brief Cognitive Assessments for Dementia Diagnosis..  Journal of Alzheimer's disease : JAD.  82:1001-1013. 2021
34. Worth the Wait: Delayed Recall after 1 Week Predicts Cognitive and Medial Temporal Lobe Trajectories in Older Adults..  Journal of the International Neuropsychological Society : JINS.  27:382-388. 2020
35. Symptomatic amyloid-related imaging abnormalities in an APOE ε4/ε4 patient treated with aducanumab..  Alzheimer's & dementia (Amsterdam, Netherlands).  12:-. 2020
36. Sex-related differences in the relationship between β-amyloid and cognitive trajectories in older adults..  Neuropsychology.  34:835-850. 2020
37. BHA-CS: A novel cognitive composite for Alzheimer's disease and related disorders..  Alzheimer's & dementia (Amsterdam, Netherlands).  12:-. 2020
38. Tau Positron Emission Tomographic Findings in a Former US Football Player With Pathologically Confirmed Chronic Traumatic Encephalopathy..  JAMA neurology.  77:517-521. 2020
39. Digital Cognitive Assessments for Dementia: Digital assessments may enhance the efficiency of evaluations in neurology and other clinics..  Practical neurology (Fort Washington, Pa.).  24-45. 2020
40. Self-Administered Cognitive Testing by Older Adults At-Risk for Cognitive Decline..  The journal of prevention of Alzheimer's disease.  7:283-287. 2020
41. Developing Cognitive Markers of Alzheimer's Disease for Primary Care: Implications for Behavioral and Global Prevention..  Journal of Alzheimer's disease : JAD.  54:1259-1272. 2016
42. Stigma, social anxiety, and illness severity in bipolar disorder: Implications for treatment..  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.  27:55-64. 2015